Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Clinical trial NCT03314662 · COMPLETED

Trial details

NCT number: NCT03314662
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2017-10-17
Primary completion: 2017-12-11
Enrollment: 1778

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.